Evaluation of Pamidronate in the Treatment of Canine Osteosarcoma


Prior studies in the human and veterinary literature suggest that the use of a bisphosphate in the treatment of canine osteosarcoma may be effective in extending overall survival.

The goal of this study is to evaluate the tolerability and efficacy of a bisphosphate, pamidronate, given in conjunction with standard of care chemotherapy for dogs with appendicular osteosaroma post amputation.

Inclusion Criteria

Dogs with osteosarcoma that have undergone surgery for removal of the affected limb.

Exclusion Criteria

Dogs must have no pre-existing renal disease.

Client Benefits

This study is not funded; so pet owners are responsible for all costs associated with this treatment.

Contact Information

Kelly Reed, Oncology Liaison
Phone: (508) 887-4682